Mekinist: A Comprehensive Guide
Mekinist (trametinib) is a cancer drug developed by Novartis Pharmaceutical Corporation. The FDA first approved this drug on May 29, 2013 [1]. It is a targeted therapy that can treat some specific types of cancer, and it can limit the...
